Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/04/2014 | US8877729 Amino acid lipids and uses thereof |
11/04/2014 | US8877726 Method and medicament for inhibiting the expression of a given gene |
11/04/2014 | US8877712 Use of Del-1 in hair, bone and cartilage regeneration |
11/04/2014 | US8877705 Biomaterial for the controlled delivery of ingredients |
11/04/2014 | US8877508 Devices and systems that deliver nitric oxide |
11/04/2014 | US8877494 Human corneal epithelial cell line PTA-120527 |
11/04/2014 | US8877473 Formulations of recombinant furin |
11/04/2014 | US8877255 Microporous zirconium silicate for the treatment of hyperkalemia |
11/04/2014 | US8877252 Polymer-based sustained release device |
11/04/2014 | US8877251 Powder compositions for inhalation |
11/04/2014 | US8877250 Hollow nano-particles and method thereof |
11/04/2014 | US8877249 Granular material for dosage forms |
11/04/2014 | US8877248 Sustained-release formulations of topiramate |
11/04/2014 | US8877247 Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist |
11/04/2014 | US8877246 Compositions and methods for augmentation and regeneration of living tissue in a subject |
11/04/2014 | US8877245 Modified release dosage forms of skeletal muscle relaxants |
11/04/2014 | US8877244 Stabilized pesticidal granules |
11/04/2014 | US8877243 Cross-linked polysaccharide composition |
11/04/2014 | US8877242 Sustained-release drug carrier composition |
11/04/2014 | US8877241 Morphine controlled release system |
11/04/2014 | US8877240 Tablet binding compositions |
11/04/2014 | US8877239 Lipid supplements for maintaining health and treatment of acute and chronic disorders |
11/04/2014 | US8877238 Film-coated tablet or granules containing as active ingredient a pyridylpyrimidine compound or a pharmaceutically acceptable salt of this compound |
11/04/2014 | US8877237 Reverse micelle system comprising nucleic acids and use thereof |
11/04/2014 | US8877236 Liposomes active in-vivo on neurodegenerative diseases |
11/04/2014 | US8877235 Patch and method for producing the same |
11/04/2014 | US8877233 Porous sponge matrix medical devices and methods |
11/04/2014 | US8877232 Bioactive compounds protection method and compositions containing the same |
11/04/2014 | US8877231 Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease |
11/04/2014 | US8877230 Controlled release delivery system for nasal applications |
11/04/2014 | US8877229 Controlled release microparticles |
11/04/2014 | US8877228 Treatment of ophthalmic conditions |
11/04/2014 | US8877227 Hydrogel nanocomposites for intraocular lens applicatons |
11/04/2014 | US8877226 Dexamethasone formulations in a biodegradable material |
11/04/2014 | US8877225 Controlled release copolymer formulation with improved release kinetics |
11/04/2014 | US8877223 Degradable hydrophilic block copolymers with improved biocompatibility for soft tissue regeneration |
11/04/2014 | US8877221 Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same |
11/04/2014 | US8877215 Compounds with modifying activity enhanced under hypoxic conditions |
11/04/2014 | US8877214 Pharmaceutical composition for modified release |
11/04/2014 | US8877208 Multivalent nanoemulsion vaccines |
11/04/2014 | US8877207 Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of Alzheimer's disease and associated methods |
11/04/2014 | US8877196 Methods of altering bone growth by administration of sost or wise antagonist or agonist |
11/04/2014 | US8877172 Zwitterionic polymer bioconjugates and related methods |
11/04/2014 | US8877168 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
11/04/2014 | US8877165 Solid preparation for oral application |
11/04/2014 | US8877164 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent |
11/04/2014 | US8877162 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery |
11/04/2014 | US8876803 System for monitoring safety in medication delivery for diabetes management |
11/04/2014 | US8876802 Methods and devices for programmable delivery of microdoses of liquid drugs |
11/04/2014 | US8876761 Intestinal brake inducing intraluminal therapeutic substance eluting devices and methods |
11/04/2014 | US8876758 Viscous formulations and their use in needle-free injection |
11/04/2014 | US8876749 Apparatus and process for producing CO2 enriched medical foam |
10/30/2014 | US20140324016 Methods and Devices for Renal Nerve Blocking |
10/30/2014 | US20140323996 Transdermal Therapeutic System for Administering an Active Substance |
10/30/2014 | US20140323994 Transdermal therapeutic system for 5-aminolevulinic acid hydrochloride |
10/30/2014 | US20140323959 Safety limits for closed-loop infusion pump control |
10/30/2014 | US20140323541 Methods And Compositions For Prevention Or Treatment Of RSV Infection Using Modified Duplex RNA Molecules |
10/30/2014 | US20140323505 Oral rinse composition and method to deliver energy supplements |
10/30/2014 | US20140323472 Methods and compositions for the delivery of a therapeutic agent |
10/30/2014 | US20140323454 Anaesthetic composition |
10/30/2014 | US20140323453 Lipobalanced long chain testosterone esters for oral delivery |
10/30/2014 | US20140323451 Methods for administering corticosteroid formulations |
10/30/2014 | US20140323433 Method for rehydrating polysaccharide particles |
10/30/2014 | US20140323415 Organic compounds |
10/30/2014 | US20140322791 Process to prepare a stable thrombin composition |
10/30/2014 | US20140322368 Method of reducing and improving the appearance of scar tissue |
10/30/2014 | US20140322367 Herpes Treatment |
10/30/2014 | US20140322345 Novel slow-releasing ophthalmic compositions comprising povidone iodine |
10/30/2014 | US20140322343 Sustained-release formulations of topiramate |
10/30/2014 | US20140322342 Co-encapsulation of live cells with oxygen-generating particles |
10/30/2014 | US20140322341 Novel hemostatic patch and uses thereof |
10/30/2014 | US20140322340 Protein-polysaccharide conjugates and use for encapsulating nutraceuticals for clear beverage applications |
10/30/2014 | US20140322336 Sustained-release microspheres and methods of making and using same |
10/30/2014 | US20140322333 Chelated nanoceria for the treatment of oxidative stress |
10/30/2014 | US20140322331 Calcipotriol monohydrate nanocrystals |
10/30/2014 | US20140322330 Methods for forming miniemulsions and use thereof for delivering bioactive agents |
10/30/2014 | US20140322328 Dry powder formulations and methods of use |
10/30/2014 | US20140322326 Particles comprising a releasable dopant therein |
10/30/2014 | US20140322325 Pharmaceutical compositions providing enhanced drug concentrations |
10/30/2014 | US20140322323 Pharmaceutical dosage form |
10/30/2014 | US20140322322 Composition comprising solanum glaucophyllum for preventing and/or treating hypocalcaemia and for stabilizing blood calcium levels |
10/30/2014 | US20140322321 Tablet capable of combatting misuse by injection |
10/30/2014 | US20140322320 Novel compositions for emesis control in cancer patients undergoing chemotherapy and methods thereof |
10/30/2014 | US20140322319 Pharmaceutical compositions |
10/30/2014 | US20140322317 Controlled release compositions |
10/30/2014 | US20140322316 Optimal Colon Targeting Technology |
10/30/2014 | US20140322313 Pharmaceutical compositions of ibuprofen and an h2 receptor antagonist |
10/30/2014 | US20140322312 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
10/30/2014 | US20140322311 Crush resistan delayed-release dosage form |
10/30/2014 | US20140322310 Gel compositions |
10/30/2014 | US20140322308 Compositions for Preventing or Treating Adverse Reactions of EGFR Inhibition |
10/30/2014 | US20140322307 Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions |
10/30/2014 | US20140322305 Sustained release enhanced lipolytic formulation for regional adipose tissue treatment |
10/30/2014 | US20140322303 Liposomal curcumin for treatment of diseases |
10/30/2014 | US20140322301 Mucin antigen vaccine |
10/30/2014 | US20140322300 Patch |
10/30/2014 | US20140322299 Controlled Release of Active Using pH |
10/30/2014 | US20140322296 Piperaquine microcapsules and compositions containing them |
10/30/2014 | US20140322293 Methods for treating conditions of the nail unit |
10/30/2014 | US20140322290 Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent |